Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
Pathology of multiple sclerosis: where do we stand?
[Retinal vasculitis as manifestation of multiple sclerosis.]
Glutathione in multiple sclerosis: More than just an antioxidant?
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
Molecular analysis of interleukin-25 exons 1 and 2 and its serum levels in Iranian patients with multiple sclerosis.
Who receives rehabilitation in canadian long-term care facilities? A cross-sectional study.
TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls.
Changes in tissue directionality reflect differences in myelin content after demyelination in mice spinal cords.
Small and Long Regulatory RNAs in the Immune System and Immune Diseases.
Distribution Patterns of 18F-Labelled Fluoromethylcholine in Normal Structures and Tumors of the Head: A PET/MRI Evaluation.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
Cerebral venous thrombosis after lumbar puncture and intravenous high dose corticosteroids: A case report of a childhood multiple sclerosis.
Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment-Past, Present, and Future Aspects.
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).
A history of multiple sclerosis investigations in Canada between 1850 and 1950.
Alemtuzumab and multiple sclerosis: Is it safe?
Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis.
The meninges: new therapeutic targets for multiple sclerosis.
Responsiveness and Clinically Meaningful Improvement, According to Disability Level, of Five Walking Measures After Rehabilitation in Multiple Sclerosis: A European Multicenter Study.
Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination.
Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery.
Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis.

Pages